MARKET

ACHV

ACHV

Achieve Life Sciences Inc
NASDAQ
5.20
+0.21
+4.21%
Closed 16:00 02/03 EST
OPEN
4.950
PREV CLOSE
4.990
HIGH
5.27
LOW
4.950
VOLUME
73.95K
TURNOVER
207.59K
52 WEEK HIGH
8.13
52 WEEK LOW
2.000
MARKET CAP
93.06M
P/E (TTM)
-1.3033
1D
5D
1M
3M
1Y
5Y
Achieve Life Sciences: All Eyes On Phase 3 Data For Smoking Cessation Drug
Seeking Alpha · 01/29 04:45
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 01/23 21:31
Maxim Group Reaffirms Their Buy Rating on Achieve Life Sciences (ACHV)
TipRanks · 01/10 19:25
Oppenheimer Adjusts Achieve Life Sciences Price Target to $17 From $20, Maintains Outperform Rating
Oppenheimer Adjusts Achieve Life Sciences Price Target to $17 From $20, Maintains Outperform Rating
MT Newswires · 01/10 09:13
Achieve Life Sciences (ACHV) Gets a Buy from H.C. Wainwright
TipRanks · 01/09 15:55
Achieve Life Sciences Announces Last Subject Dosed In Phase 3 ORCA-3 Trial Of Cytisinicline For Smoking Cessation
Benzinga · 01/09 13:08
BRIEF-Achieve Life Sciences Inc Files Prospectus Related To Offering Of Upto 12.3 Mln Shares
Reuters · 12/29/2022 21:40
Achieve Life Sciences Receives US Patent for New Formulation of Cytisinicline
Achieve Life Sciences Receives US Patent for New Formulation of Cytisinicline
MT Newswires · 12/21/2022 10:38
More
About ACHV
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring plant-based alkaloid from the seeds of the Laburnum anagyroides plant. Cytisinicline is structurally similar to nicotine and a mechanism of action that is both agonistic and antagonistic. The Company is aid in smoking cessation, or nicotine addiction, by interacting with nicotine receptors in the brain by reducing the severity of nicotine withdrawal symptoms through agonistic effects on nicotine receptors and by reducing the reward and satisfaction associated with nicotine through antagonistic properties. The Company’s has two prescription oral treatments for smoking cessation are available in the United States: Chantix (varenicline) and Zyban (bupropion).

Webull offers kinds of Achieve Life Sciences Inc stock information, including NASDAQ:ACHV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACHV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACHV stock methods without spending real money on the virtual paper trading platform.